[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 27, 1994

Ethicist Faults Human Research Subject Protection

JAMA. 1994;271(16):1228-1229. doi:10.1001/jama.1994.03510400014004

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

THE SYSTEM that is supposed to protect human subjects who participate in research studies is flawed. The result is failure to protect such persons adequately, said speakers at a Washington, DC, meeting.

Two recently publicized examples illustrate the point: In controlled field trials of the efficacy of pertussis vaccine, some children were denied the benefits of the vaccine; in another study involving schizophrenic patients, the subjects were not told the full extent of the risks of participation.

The flaw in the system is the failure to keep in working order the mechanism of open public discussion of difficult cases by the Ethics Advisory Board that was set up in 1977 and allowed to lapse in 1980, says noted medical ethicist Albert R. Jonsen, PhD, of the University of Washington School of Medicine, Seattle.

If that mechanism had been in place, Jonsen argued at a meeting of the Congressional Biomedical Research

First Page Preview View Large
First page PDF preview
First page PDF preview
×